CMD represents Alexander Capital and WallachBeth Capital in the IPO of Summit Semiconductor, Inc. on to the Nasdaq

NEW YORK, NEW YORK, July 27, 2018 — Summit Semiconductor, a technology company that delivers the wireless immersive sound experience with patented technology supporting the WiSA™ (Wireless Speaker and Audio) interoperability standard, announced the pricing of its initial public offering of 2,400,000 shares of its common stock at an initial offering price of $5.00 per […]

CMD represents Network 1 Financial in the IPO of Hancock Jaffe Laboratories Inc. on to the Nasdaq

Hancock Jaffe Laboratories, which is developing bioprosthetic devices for cardiovascular surgeries, raised $8 million by offering an upsized 1.5 million units at $5, below $6 to $8 range. The company initially filed to raise $8 million by offering 1.2 million units at the same range. Each unit consists of one share of common stock and […]

Carmel, Milazzo & DiChiara LLP client CTT Pharmaceutical (OTC: CTTH) receives strategic investment from Aurora Cannabis (TSE: ACB), one of the largest cannabis companies in the world

Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CTT Pharmaceutical Holdings Inc. (“CTT”) (US-OTC: CTTH) today announced that Aurora is acquiring an initial 9.14% ownership interest in CTT via way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement […]

CMD Partner Ross D. Carmel Wins Over $2.7 Million in Damages, Including Punitive Damages

Press Release – New York, NY – December 12, 2017 – Securities and corporate law firm Carmel, Milazzo & DiChiara LLP announced today that attorney Ross D. Carmel successfully represented four clients in an AAA Arbitration which awarded over $2.7 million dollars in damages. The underlying case involved four former employees, who were also investors […]

Carmel, Milazzo & DiChiara LLP Represents Co-Diagnostics, Inc. (NASDAQ: CODX) in $7 Million Initial Public Offering (IPO)

Press Release – New York, NY – July 13, 2017 –  Securities and corporate law firm Carmel, Milazzo & DiChiara LLP announced today that it has represented Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests, in a $7 Million Initial Public Offering on […]

CMD Partner Ross D. Carmel Wins Appeal Before the New York State Supreme Court, Appellate Division, First Department

Press Release – New York, NY – June 14, 2017 – Securities and corporate law firm Carmel, Milazzo & DiChiara, LLP (“CMD”) announces that it has successfully won an appeal before the New York State Supreme Court, Appellate Division, First Department.  The Court, upholding the lower court’s decision, directed respondent to, among other things, issue and deliver […]

CMD Client CTT Pharmaceutical Holdings (CTTH) Announces Completion of Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer with CanniMed Therapeutics Inc. (CMED)

SASKATOON, Saskatchewan & STONEY CREEK, Ontario–(BUSINESS WIRE)–Today, CanniMed Therapeutics Inc. (TSX: CMED) and CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) have entered into a definitive contractual relationship for the licensing of CTT’s Orally Dissolvable Thin Film (ODF) Wafer technology. This industry-first collaboration includes the licensing of six patents related to cannabinoid and opioid delivery for pain management, […]

CMD client, Manhattan Ventures Partners, featured in Forbes regarding the launch of the MVP All-Star Fund to get Pro Athletes into Tech Unicorns.

Rashaun Williams hard at work behind NBA players Steph Curry, Andre Iguodala and Lou Amundson. (Credit: MVP All-Star Fund) Press Release – New York, NY – February 3, 2017 –  Securities and corporate law firm Carmel, Milazzo & DiChiara LLP announced today that its client, Manhattan Ventures Partners, was featured in Forbes regarding the launch of the MVP All-Star Fund […]